Rob graduated with a BEng (Hons) Chemical Engineering Degree from University College Dublin in 2010, followed by an MSc in Biopharmaceutical Science in 2013. In 2010, he joined Eli Lilly, where he has been involved in the design, start-up, and operation of Lilly's four commercial mAb facilities in Ireland. Rob is currently a Director in Lilly's Engineering Technology Center, where he specialises in Bioprocess and Facility Design, Facility Fit Modelling, and Next Generation Bioprocessing.